About half of Americans "strongly" or "somewhat" favor having Medicare and Medicaid cover weight-loss drugs for people who ...

The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access ...

A new paper by the Institute for Clinical and Economic Review (ICER) looks at the cost-effectiveness versus affordability issue of obesity medications such as Wegovy and Zepbound.

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...

SAN ANTONIO — Obesity has become a global health crisis, especially here in the U.S. In today's Healthy SA we look into ...

Semaglutide is an injectable medication that treats type 2 diabetes and obesity by regulating blood sugar levels. A ...

Such medications are just one part of a necessary, holistic approach that includes diet, exercise, and addressing significant ...

President Trump’s administration has made the decision not to cover highly-popular obesity treatments under the 2026 Medicare ...

Health and Human Services Secretary Robert F. Kennedy Jr. spoke with CBS News in an exclusive interview. Here are some ...

After massive gains in the past five years on the heels of the weight loss blockbuster Zepbound, Eli Lilly & Co (LLY) stock ...

These drugs have been hailed as not only life-changing but also life-saving. However, insurance does not cover the drugs for ...